Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2005 Sep 27;65(6):807-11.

The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.

Author information

  • 1Division of Clinical Pharmacology-Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Erratum in

  • Neurology. 2005 Dec 27;65(12):1992.

Abstract

OBJECTIVE:

To determine whether interferon therapy during human pregnancy increases reproductive risks in women.

METHODS:

This longitudinal, controlled cohort study consisted of three groups of women: an exposed group, a disease matched unexposed group, and a healthy comparative group. Subjects were selected from women contacting the Motherisk Program regarding maternal beta interferon exposure, mostly for multiple sclerosis during pregnancy, from 1997 to 2004. After delivery all of the women were re-contacted for a follow-up interview regarding maternal health, pregnancy outcome, and neonatal health.

RESULTS:

The study group (n = 16 women, 23 pregnancies) were exposed to interferon beta-1a (Avonex, Rebif) and interferon-1b (Betaseron). There was a decrease in mean birth weight in the exposed group (3,189 +/- 416 g) as compared to healthy controls (3,783 +/- 412 g, p = 0.002). Women exposed to beta interferon had a higher rate of miscarriages and stillbirths (39.1%) vs healthy controls (5%) (p = 0.03), even after correction for potential confounders. There were two major malformations (abnormality in the X chromosome, Down's syndrome) among exposed fetuses.

CONCLUSIONS:

Beta interferon therapy in the first trimester of pregnancy appears to be associated with an increased risk for fetal loss and low birth weight.

Comment in

PMID:
16186517
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk